Onglets principaux
Exporter 27 resultats:
Filtres: Auteur is Pierre Hubin
Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium,
, Vaccine: X, Jan-06-2024, Volume 18, (2024)
Epidemiologische surveillance van invasieve pneumokokkeninfecties (IPD) - 2019 tot 2022,
, online, 2024-01-21, (2024)
Surveillance épidémiologique des infections invasives à pneumocoques - 2019 à 2022,
, online, 2024-01-21, (2024)
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 chez les personnes présentant des maladies sous-jacentes en Belgique,
, 04/2023, Brussels, Belgium, p.39, (2023)
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.,
, Euro Surveill, 2023 Jun, Volume 28, Issue 26, (2023)
Factors underlying COVID-19 booster vaccine uptake among adults in Belgium,
, BMC Res Notes, 2023 Nov 11, Volume 16, Issue 1, (2023)
Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium,
, European Society of Clinical Microbiology and Infectious Diseases, 17/04/2023, Copenhagen, Denmark, (2023)
Factors underlying COVID-19 booster vaccine uptake among fully vaccinated adults in Belgium,
, Scientific Seminar Infectious Diseases, 11/05/2023, Brussels, Belgium, (2023)
A new data collection system for Epilabo: the network of sentinel laboratories,
, Scientific Seminar Infectious Diseases, 11/05/2023, Brussels, Belgium, (2023)
Sociodemographic and socioeconomic disparities in COVID-19 vaccine uptake in Belgium: a nationwide record linkage study.,
, J Epidemiol Community Health, 2023 Dec 26, (2023)
Vaccinatiegraad en epidemiologische impact van de COVID-19-vaccinatiecampagne bij personen met onderliggende gezondheidsaandoeningen in België,
, 04/2023, Brussels, Belgium, p.39, (2023)
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022,
, Vaccine, Jan-04-2023, (2023)
Vaccine effectiveness of the second and third COVID-19 boosters in Belgium (administered during 2022 autumn campaign),
, 09/2023, Brussels, Belgium, p.8, (2023)
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 chez les 5 à 17 ans en Belgique,
, Dec 2022, p.31, (2022)
COVID-19 vaccine effectiveness in adolescents: a test negative case-control study in Belgium,
, Sep 2022, (2022)
Disparities in second booster coverages and impact on COVID-19 cases and hospital admissions during summer 2022,
, Nov 2022, p.5, (2022)
Guidance on interpretation of the COVID-19 vaccine impact on infections in the Sciensano weekly report,
, May 2022, p.6, (2022)
Incidence and Risk Factors of COVID-19 Vaccine Breakthrough Infections: A Prospective Cohort Study in Belgium.,
, Viruses, 2022 Apr 13, Volume 14, Issue 4, (2022)
Investigating COVID-19 Vaccine Impact on the Risk of Hospitalisation through the Analysis of National Surveillance Data Collected in Belgium.,
, Viruses, 2022 Jun 16, Volume 14, Issue 6, (2022)
Risk factors associated with breakthrough SARS-CoV-2 infections after vaccination: a prospective cohort study in Belgium,
, Apr 2022, (2022)
Vaccinatiegraad en epidemiologische impact van de COVID-19-vaccinatiecampagne bij 5- tot 17-jarigen in België,
, Dec 2022, p.31, (2022)
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.,
, Vaccine, 2022 May 11, Volume 40, Issue 22, (2022)
Couverture vaccinale et impact épidémiologique de la campagne de vaccination COVID-19 en Belgique. Données jusqu’au 31 octobre 2021 inclus,
, Nov 2021, Belgium, p.53, (2021)